China Point-Of-Care Testing (POCT) Market Research Report 2022

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,400	149 Pages	QYResearch Group	December, 2022	QYR17582498

Best Price Guarantee
Price	from $3,400
Length	149 Pages
Publisher	QYResearch Group
Published Date	December, 2022
SKU	QYR17582498

China Point-Of-Care Testing (POCT) Market Research Report 2022

Market Analysis and Insights: China Point-of-Care Testing (POCT) Market

Due to the COVID-19 pandemic, the China Point-of-Care Testing (POCT) market size is estimated to be worth US$ 2341 million in 2022 and is forecast to a readjusted size of US$ 4959 million by 2028 with a CAGR of 13.33% during the review period. Fully considering the economic change by this health crisis, Blood Glucose Testing accounting for 43.75% of the Point-of-Care Testing (POCT) China market in 2021, is projected to value US$ 1797 million by 2028, growing at a revised 10.8% CAGR in the forecast period.

In China, the key manufacturers of Point-of-Care Testing (POCT) include Roche, Abbott, LifeScan, Siemens Healthineers, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux, and ARKRAY, etc. In 2021, the top five players have a share approximately XX% in terms of revenue.

China Point-of-Care Testing (POCT) Scope and Segment

Point-of-Care Testing (POCT) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the China Point-of-Care Testing (POCT) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.

Segment by Type

Blood Glucose Testing

Infectious Diseases Testing

Cardiac Markers Testing

Coagulation Testing

Pregnancy and Fertility Testing

Blood Gas/Electrolytes Testing

Urinalysis Testing

Other

Segment by Application

Clinics

Hospitals

Laboratory

Others

By Company

Roche

Abbott

LifeScan

Siemens Healthineers

Danaher

Ascensia

BioMerieux

ARKRAY

Sinocare

Wondfo

Yuwell

Runbio

KHB

Wuhan Easy Diagnosis

J.H.Bio-Tec

Getein Biotech

ReLIA

BIOUHAN

Beijing Wantai BioPharm

Hotgen

Intec PRODUCT

Shenzhen YHLO

Kang Hua

1 Study Coverage: 1.1 Point-of-care Testing (Poct) Product Introduction; 1.2 Market By Type; 1.2.1 China Point-of-care Testing (Poct) Market Size Growth Rate By Type, 2017 Vs 2021 Vs 2028; 1.2.2 Blood Glucose Testing; 1.2.3 Infectious Diseases Testing; 1.2.4 Cardiac Markers Testing; 1.2.5 Coagulation Testing; 1.2.6 Pregnancy And Fertility Testing; 1.2.7 Blood Gas/Electrolytes Testing; 1.2.8 Urinalysis Testing; 1.3 Market By Application; 1.3.1 China Point-of-care Testing (Poct) Market Size Growth Rate By Application, 2017 Vs 2021 Vs 2028; 1.3.2 Clinics; 1.3.3 Hospitals; 1.3.4 Laboratory; 1.4 China Point-of-care Testing (Poct) Sales Estimates And Forecasts 2017-2028; 1.5 China Point-of-care Testing (Poct) Revenue Estimates And Forecasts 2017-2028; 1.6 Study Objectives; 1.7 Years Considered
2 Competition By Manufacturers: 2.1 China Point-of-care Testing (Poct) Sales By Manufacturers; 2.1.1 China Point-of-care Testing (Poct) Sales By Manufacturers (2017-2022); 2.1.2 China Point-of-care Testing (Poct) Sales Market Share By Manufacturers (2017-2022); 2.1.3 Top Largest Manufacturers Of Point-of-care Testing (Poct) In 2021 In China; 2.2 China Point-of-care Testing (Poct) Revenue By Manufacturers; 2.2.1 China Point-of-care Testing (Poct) Revenue By Manufacturers (2017-2022); 2.2.2 China Point-of-care Testing (Poct) Revenue Market Share By Manufacturers (2017-2022); 2.2.3 China Top Companies By Point-of-care Testing (Poct) Revenue In 2021; 2.3 China Point-of-care Testing (Poct) Sales Price By Manufacturers (2017-2022); 2.4 Analysis Of Competitive Landscape; 2.4.1 Manufacturers Market Concentration Ratio (Cr5 And Hhi); 2.4.2 China Point-of-care Testing (Poct) By Company Type (Tier 1, Tier 2, And Tier 3); 2.4.3 China Point-of-care Testing (Poct) Manufacturers Geographical Distribution; 2.5 Mergers & Acquisitions, Expansion Plans
3 Market Size By Type: 3.1 China Point-of-care Testing (Poct) Sales By Type; 3.1.1 China Point-of-care Testing (Poct) Historical Sales By Type (2017-2022); 3.1.2 China Point-of-care Testing (Poct) Forecasted Sales By Type (2023-2028); 3.1.3 China Point-of-care Testing (Poct) Sales Market Share By Type (2017-2028); 3.2 China Point-of-care Testing (Poct) Revenue By Type; 3.2.1 China Point-of-care Testing (Poct) Historical Revenue By Type (2017-2022); 3.2.2 China Point-of-care Testing (Poct) Forecasted Revenue By Type (2023-2028); 3.2.3 China Point-of-care Testing (Poct) Revenue Market Share By Type (2017-2028); 3.3 China Point-of-care Testing (Poct) Price By Type; 3.3.1 China Point-of-care Testing (Poct) Price By Type (2017-2022); 3.3.2 China Point-of-care Testing (Poct) Price Forecast By Type (2023-2028)
4 Market Size By Application: 4.1 China Point-of-care Testing (Poct) Sales By Application; 4.1.1 China Point-of-care Testing (Poct) Historical Sales By Application (2017-2022); 4.1.2 China Point-of-care Testing (Poct) Forecasted Sales By Application (2023-2028); 4.1.3 China Point-of-care Testing (Poct) Sales Market Share By Application (2017-2028); 4.2 China Point-of-care Testing (Poct) Revenue By Application; 4.2.1 China Point-of-care Testing (Poct) Historical Revenue By Application (2017-2022); 4.2.2 China Point-of-care Testing (Poct) Forecasted Revenue By Application (2023-2028); 4.2.3 China Point-of-care Testing (Poct) Revenue Market Share By Application (2017-2028); 4.3 China Point-of-care Testing (Poct) Price By Application; 4.3.1 China Point-of-care Testing (Poct) Price By Application (2017-2022); 4.3.2 China Point-of-care Testing (Poct) Price Forecast By Application (2023-2028)
5 Corporate Profile: 5.1 Roche; 5.1.1 Roche Corporation Information; 5.1.2 Roche Overview; 5.1.3 Roche In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.1.4 Roche Point-of-care Testing (Poct) Product Introduction; 5.1.5 Roche Recent Developments; 5.2 Abbott; 5.2.1 Abbott Corporation Information; 5.2.2 Abbott Overview; 5.2.3 Abbott In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.2.4 Abbott Point-of-care Testing (Poct) Product Introduction; 5.2.5 Abbott Recent Developments; 5.3 Lifescan; 5.3.1 Lifescan Corporation Information; 5.3.2 Lifescan Overview; 5.3.3 Lifescan In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.3.4 Lifescan Point-of-care Testing (Poct) Product Introduction; 5.3.5 Lifescan Recent Developments; 5.4 Siemens Healthineers; 5.4.1 Siemens Healthineers Corporation Information; 5.4.2 Siemens Healthineers Overview; 5.4.3 Siemens Healthineers In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.4.4 Siemens Healthineers Point-of-care Testing (Poct) Product Introduction; 5.4.5 Siemens Healthineers Recent Developments; 5.5 Danaher; 5.5.1 Danaher Corporation Information; 5.5.2 Danaher Overview; 5.5.3 Danaher In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.5.4 Danaher Point-of-care Testing (Poct) Product Introduction; 5.6 Ascensia; 5.6.1 Ascensia Corporation Information; 5.6.2 Ascensia Overview; 5.6.3 Ascensia In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.6.4 Ascensia Point-of-care Testing (Poct) Product Introduction; 5.6.5 Ascensia Recent Developments; 5.7 Biomerieux; 5.7.1 Biomerieux Corporation Information; 5.7.2 Biomerieux Overview; 5.7.3 Biomerieux In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.7.4 Biomerieux Point-of-care Testing (Poct) Product Introduction; 5.8 Arkray; 5.8.1 Arkray Corporation Information; 5.8.2 Arkray Overview; 5.8.3 Arkray In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.8.4 Arkray Point-of-care Testing (Poct) Product Introduction; 5.8.5 Arkray Recent Developments; 5.9 Sinocare; 5.9.1 Sinocare Corporation Information; 5.9.2 Sinocare Overview; 5.9.3 Sinocare In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.9.4 Sinocare Point-of-care Testing (Poct) Product Introduction; 5.10 Wondfo; 5.10.1 Wondfo Corporation Information; 5.10.2 Wondfo Overview; 5.10.3 Wondfo In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.10.4 Wondfo Point-of-care Testing (Poct) Product Introduction; 5.11 Yuwell; 5.11.1 Yuwell Corporation Information; 5.11.2 Yuwell Overview; 5.11.3 Yuwell In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.11.4 Yuwell Point-of-care Testing (Poct) Product Introduction; 5.12 Runbio; 5.12.1 Runbio Corporation Information; 5.12.2 Runbio Overview; 5.12.3 Runbio In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.12.4 Runbio Point-of-care Testing (Poct) Product Introduction; 5.13 Khb; 5.13.1 Khb Corporation Information; 5.13.2 Khb Overview; 5.13.3 Khb In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.13.4 Khb Point-of-care Testing (Poct) Product Introduction; 5.14 Wuhan Easy Diagnosis; 5.14.1 Wuhan Easy Diagnosis Corporation Information; 5.14.2 Wuhan Easy Diagnosis Overview; 5.14.3 Wuhan Easy Diagnosis In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.14.4 Wuhan Easy Diagnosis Point-of-care Testing (Poct) Product Introduction; 5.15 J.H.Bio-tec; 5.15.1 J.H.Bio-tec Corporation Information; 5.15.2 J.H.Bio-tec Overview; 5.15.3 J.H.Bio-tec In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.15.4 J.H.Bio-tec Point-of-care Testing (Poct) Product Introduction; 5.16 Getein Biotech; 5.16.1 Getein Biotech Corporation Information; 5.16.2 Getein Biotech Overview; 5.16.3 Getein Biotech In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.16.4 Getein Biotech Point-of-care Testing (Poct) Product Introduction; 5.17 Relia; 5.17.1 Relia Corporation Information; 5.17.2 Relia Overview; 5.17.3 Relia In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.17.4 Relia Point-of-care Testing (Poct) Product Introduction; 5.18 Biouhan; 5.18.1 Biouhan Corporation Information; 5.18.2 Biouhan Overview; 5.18.3 Biouhan In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.18.4 Biouhan Point-of-care Testing (Poct) Product Introduction; 5.19 Beijing Wantai Biopharm; 5.19.1 Beijing Wantai Biopharm Corporation Information; 5.19.2 Beijing Wantai Biopharm Overview; 5.19.3 Beijing Wantai Biopharm In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.19.4 Beijing Wantai Biopharm Point-of-care Testing (Poct) Product Introduction; 5.20 Hotgen; 5.20.1 Hotgen Corporation Information; 5.20.2 Hotgen Overview; 5.20.3 Hotgen In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.20.4 Hotgen Point-of-care Testing (Poct) Product Introduction; 5.21 Intec Product; 5.21.1 Intec Product Corporation Information; 5.21.2 Intec Product Overview; 5.21.3 Intec Product In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.21.4 Intec Product Point-of-care Testing (Poct) Product Introduction; 5.22 Shenzhen Yhlo; 5.22.1 Shenzhen Yhlo Corporation Information; 5.22.2 Shenzhen Yhlo Overview; 5.22.3 Shenzhen Yhlo In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.22.4 Shenzhen Yhlo Point-of-care Testing (Poct) Product Introduction; 5.23 Kang Hua; 5.23.1 Kang Hua Corporation Information; 5.23.2 Kang Hua Overview; 5.23.3 Kang Hua In China: Point-of-care Testing (Poct) Sales, Price, Revenue And Gross Margin (2017-2022); 5.23.4 Kang Hua Point-of-care Testing (Poct) Product Introduction
6 Industry Chain And Sales Channels Analysis: 6.1 Point-of-care Testing (Poct) Industry Chain Analysis; 6.2 Point-of-care Testing (Poct) Key Raw Materials; 6.2.1 Key Raw Materials; 6.2.2 Raw Materials Key Suppliers; 6.3 Point-of-care Testing (Poct) Production Mode & Process; 6.4 Point-of-care Testing (Poct) Sales And Marketing; 6.4.1 Point-of-care Testing (Poct) Sales Channels; 6.4.2 Point-of-care Testing (Poct) Distributors; 6.5 Point-of-care Testing (Poct) Customers
7 Point-of-care Testing (Poct) Market Dynamics: 7.1.1 Point-of-care Testing (Poct) Industry Trends; 7.1.2 Point-of-care Testing (Poct) Market Drivers; 7.1.3 Point-of-care Testing (Poct) Market Challenges; 7.1.4 Point-of-care Testing (Poct) Market Restraints
8 Key Findings In The China Point-of-care Testing (Poct) Study
9 Appendix: 9.1 Research Methodology; 9.1.1 Methodology/Research Approach; 9.1.2 Data Source; 9.2 Author Details; 9.3 Disclaimer
List Of Tables: Table 1. China Point-of-care Testing (Poct) Market Size Growth Rate By Type, 2017 Vs 2021 Vs 2028 (Us$ Million); Table 2. China Point-of-care Testing (Poct) Market Size Growth Rate By Application, 2017 Vs 2021 Vs 2028 (Us$ Million); Table 3. China Point-of-care Testing (Poct) Sales By Manufacturers (2017-2022) & (M Unit); Table 4. China Point-of-care Testing (Poct) Sales Share By Manufacturers (2017-2022); Table 5. China Point-of-care Testing (Poct) Revenue By Manufacturers (2017-2022) & (Us$ Million); Table 6. China Point-of-care Testing (Poct) Revenue Market Share By Manufacturers (2017-2022); Table 7. Point-of-care Testing (Poct) Price By Manufacturers (2017-2022) & (Us$/K Unit); Table 8. China Point-of-care Testing (Poct) Manufacturers Market Concentration Ratio (Cr5 And Hhi); Table 9. China Point-of-care Testing (Poct) By Company Type (Tier 1, Tier 2, And Tier 3) & (Based On The Revenue In Point-of-care Testing (Poct) As Of 2021); Table 10. Point-of-care Testing (Poct) Manufacturing Base Distribution And Headquarters; Table 11. Founded Date Of Point-of-care Testing (Poct) Manufacturers; Table 12. Mergers & Acquisitions, Expansion Plans; Table 13. China Point-of-care Testing (Poct) Sales By Type (2017-2022) & (M Unit); Table 14. China Point-of-care Testing (Poct) Sales By Type (2023-2028) & (M Unit); Table 15. China Point-of-care Testing (Poct) Sales Share By Type (2017-2022); Table 16. China Point-of-care Testing (Poct) Sales Share By Type (2023-2028); Table 17. China Point-of-care Testing (Poct) Revenue By Type (2017-2022) & (Us$ Million); Table 18. China Point-of-care Testing (Poct) Revenue By Type (2023-2028) & (Us$ Million); Table 19. China Point-of-care Testing (Poct) Revenue Share By Type (2017-2022); Table 20. China Point-of-care Testing (Poct) Revenue Share By Type (2023-2028)